Ignite Creation Date:
2024-05-06 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 12:46 PM
Study NCT ID:
NCT03538171
Status:
UNKNOWN
Last Update Posted:
2021-07-09
First Post:
2018-04-27
Brief Title:
Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer
Sponsor:
Taizhou EOC Pharma Co Ltd
Organization:
Taizhou EOC Pharma Co Ltd
Organization Data
Organization:
Taizhou EOC Pharma Co Ltd
Class:
INDUSTRY
Study ID:
EOC103A3101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Taizhou EOC Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None